Position: Elected Member Academia
Organisation: Royal Institute of Technology (KTH)
Location: Stockholm, Sweden
Email: mathias@biotech.kth.se

Mathias Uhlen is Professor of Microbiology at the Royal Institute of Technology (KTH), Stockholm, Sweden. Dr Uhlen is member of the Royal Swedish Academy of Engineering Science (IVA), the Royal Swedish Academy of Science (KVA) and the European Molecular Biology Organization (EMBO).

He was Vice-President of the Royal Institute of Technology (KTH), responsible for external relations, from 1999 to 2001. He was the chairman of the Swedish Biochemical and Molecular Biology Society (SFMB) from 1994 to 1999. Dr Uhlen has more than 260 publications in the field of biotechnology and his key scientific achievements includes cloning of protein A and protein G (used for IgG-purifications), development of solid phase sequencing and streptavidin magnetic beads, development of the first gene fusion system for affinity purification, Pyrosequencing (a novel sequencing method) and novel combinatorial binding molecules called Affibodies.

He has founded several companies during the last five years, including Pyrosequencing AB ( Biotage AB ), Affibody AB , SweTreeGenomics AB , Magnetic Biosolutions AB and Creative Peptides AB. He has received numerous awards, including: The Svedberg prize in 1992, the Göran Gustavsson prize in 1993, the gold medal of the Royal Swedish Academy of Engineering Sciences in 2004, the Most Noble Order of the Seraphim - the Order of His Majesty the King in 2004 and the Akzo Noble Award 2005.